Compare BRNX & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRNX | NUWE |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5M | 3.2M |
| IPO Year | 2022 | 2012 |
| Metric | BRNX | NUWE |
|---|---|---|
| Price | $1.06 | $0.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 107.7K | ★ 2.5M |
| Earning Date | 09-09-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,270,000.00 |
| Revenue This Year | $35,081.65 | $19.32 |
| Revenue Next Year | N/A | $12.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $0.41 |
| 52 Week High | $10.36 | $24.70 |
| Indicator | BRNX | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 31.29 | 31.88 |
| Support Level | N/A | $0.41 |
| Resistance Level | $2.49 | $1.46 |
| Average True Range (ATR) | 0.17 | 0.06 |
| MACD | -0.07 | 0.05 |
| Stochastic Oscillator | 15.09 | 33.33 |
BrenX Ltd is reshaping industrial energy to make it cleaner, more reliable, and lower cost. Building on its proprietary bGen thermal energy storage technology, which converts electricity and recovered heat into dispatchable energy, BrenX develops, owns, operates, and optimizes energy assets that serve industrial customers and data centers. From local generation and storage to grid connectivity and intelligent energy management, BrenX brings together technologies and infrastructure to create complete energy platforms around customer needs, with flexible energy assets designed to meet growing energy demand.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.